Mitochondrial Fusion Exploits a Therapeutic Vulnerability of Pancreatic Cancer
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer Meifang Yu, … , Anirban Maitra, Cullen M. Taniguchi JCI Insight. 2019. https://doi.org/10.1172/jci.insight.126915. Research In-Press Preview Gastroenterology Oncology Graphical abstract Find the latest version: https://jci.me/126915/pdf Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer Meifang Yu1, Nicholas D. Nguyen1, Yanqing Huang1, Daniel Lin1, Tara N. Fujimoto1, Jessica M. Molkentine2, Amit Deorukhkar3, Ya’an Kang3, F. Anthony San Lucas4, Conrad J. Fernandes1, Eugene J. Koay5, Sonal Gupta6, 7, Haoqiang Ying8, Albert C. Koong5, Joseph M. Herman5, Jason B. Fleming9, Anirban Maitra6, 7, Cullen M. Taniguchi1,5†* Short title: Modulating mitochondrial dynamics to inhibit PDAC Brief Summary: Mitochondrial fusion in pancreatic cancer cells induces mitophagy, Which alters tumor energetics and correlates With improved survival in mouse models. Affiliations: 1 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2 Department of Radiation Oncology, University of Pittsburgh, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA. 3 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 4 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 5 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 6 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 7 Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 8 Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[Show full text]